Genotropin 16iu (5.3mg)

Genotropin 16IU (5.3mg)

Genotropin 16IU (5.3mg) is a prescription human growth hormone medicine containing somatropin, a recombinant form of human growth hormone. This presentation contains 5.3 mg, equivalent to 16 IU, and is supplied in a pre-filled GoQuick injection pen designed for subcutaneous administration. Pfizer manufactures Genotropin, and you should use it only as prescribed and under the supervision of a qualified healthcare professional.

General Information

Manufacturer: Pfizer
Active substance: Somatropin (recombinant human growth hormone)
Strength: 5.3 mg / 16 IU
Dosage form: Powder and solvent for solution for injection
Administration route: Subcutaneous injection
Pack: 1 pre-filled multidose GoQuick injection pen

What is Genotropin 16IU (5.3mg)?

Somatropin has the same amino-acid structure as naturally occurring human growth hormone. Human growth hormone is involved in normal growth, bone development, body composition, and metabolic processes. Genotropin is produced using recombinant technology and is intended for patients with specific medical conditions in which growth hormone treatment is clinically appropriate.

The 5.3 mg Genotropin GoQuick presentation combines the medicine and supplied solvent within a two-chamber cartridge. The medicine is reconstituted before use according to the device instructions. The GoQuick system is a pre-filled, multidose, disposable pen, so the cartridge does not need to be replaced during use.

Medical Uses

Genotropin 16IU (5.3mg) is prescribed for selected growth disorders in children and for growth hormone deficiency in adults. Depending on the approved labeling in the patient’s country, indications can include pediatric growth hormone deficiency, Turner syndrome, growth problems associated with being born small for gestational age, Prader-Willi syndrome, idiopathic short stature, and adult growth hormone deficiency.

The exact indication, treatment plan, dose, and duration must be determined by the prescribing healthcare professional. Genotropin should not be used for bodybuilding, athletic performance enhancement, or other non-prescribed purposes.

GoQuick Pen and Product Handling

The Genotropin 5.3 mg GoQuick pen is intended for repeated doses from the same pen after reconstitution. The official device instructions should be followed carefully when preparing and using the pen. A new sterile needle should be used for each injection, and the pen should never be shared with another person.

Before use, check that the packaging is intact and confirm the product name, strength, batch information, and expiry date. After reconstitution, the solution should be inspected before administration. It should not be used if the solution appears abnormal or contains visible particles.

Storage

Unmixed Genotropin 16IU (5.3mg) should be stored according to the temperature and light-protection instructions supplied with the medicine. Pfizer’s instructions for the GoQuick pen specify refrigerated storage at 2°C to 8°C and protection from light. The product must not be frozen.

After the medicine has been mixed, the GoQuick pen is also kept refrigerated. Pfizer instructs users to discard the pen 28 days after mixing, even if some medicine remains. The needle should be removed before storage, and the pen should be kept capped.

Important Safety Information

Genotropin 16IU (5.3mg) is an active prescription hormone and is not suitable for every patient. A healthcare professional should review the patient’s medical history, current medicines, treatment indication, and relevant laboratory or clinical findings before therapy begins.

Possible adverse effects can include fluid retention, joint or muscle discomfort, stiffness, changes in sensation, headache, and injection-site reactions. Other important risks and contraindications are described in the official prescribing information and patient leaflet. Patients should contact their healthcare professional if they develop new, persistent, or concerning symptoms during treatment.

People with diabetes, thyroid disorders, previous cancer, intracranial problems, severe respiratory problems, or other significant medical conditions may require additional evaluation or monitoring. Do not start, stop, or adjust treatment without medical supervision.

Product Verification

Because Genotropin 16IU (5.3mg) requires controlled storage and careful handling, packaging and product integrity are important. Check the manufacturer information, strength, expiry date, batch details, pen condition, and storage history before use. Product labeling can differ between countries, so patients should follow the leaflet supplied with their specific pack and the instructions provided by their prescriber or pharmacist.